SCM LifeScience Co

SCM LifeScience Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of SCM LifeScience Co (298060.KQ) as of Nov 19, 2026 is -8.24. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -3.25 — a change of 153.42% (lower).

EV/EBITDA

-8.24

YoY

153.42%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of SCM LifeScience Co is 2025 -8.24 . EV/EBITDA (Enterprise Value to EBITDA) of SCM LifeScience Co was 2024 -3.25 . It decreases by 153.42% lower compared to the previous year.

The SCM LifeScience Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2017
-7.89 KRW
Jan 1, 2018
-2.67 KRW
Jan 1, 2020
-0.63 KRW
Jan 1, 2021
-1.68 KRW
Jan 1, 2022
-3.13 KRW
Jan 1, 2023
-1.59 KRW
Jan 1, 2024
-3.25 KRW
Jan 1, 2025
-8.24 KRW
The SCM LifeScience Co EV/EBITDA history
YEAREV/EBITDAYoY
-8.24+153.42%
-3.25+103.95%
-1.59-49.05%
-3.13+86.29%
-1.68+167.69%
-0.63-76.50%
-2.67-66.18%
-7.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCM LifeScience Co Stock analysis

What does SCM LifeScience Co do? SCM LifeScience Co Ltd is a biotechnology company headquartered in Incheon, South Korea. The company focuses on the development and production of cell therapy products, including adult stem cell therapies. It also engages in agency testing for cell production and quality assurance, as well as providing adult stem cell consulting services. Additionally, SCM LifeScience operates in the cosmetics and hair growth protein manufacturing sectors. The company has 55 full-time employees. SCM LifeScience completed its initial public offering (IPO) on June 17, 2020. Its stock is listed under the ticker 298060.KQ on the Korean stock exchange, with an ISIN code of KR7298060005. The company's website is http://www.scmlifescience.com/. SCM LifeScience operates within the healthcare sector, specifically within the biotechnology industry. It does not provide details on its founding year, specific product names, or financial figures beyond the IPO date and employee count. The company's activities span drug development for stem cell therapy, cell production testing, and manufacturing of related products. SCM LifeScience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCM LifeScience Co stock

EV/EBITDA (Enterprise Value to EBITDA) of SCM LifeScience Co is -8.24 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of SCM LifeScience Co changed from -3.25 to -8.24, representing a 153.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) SCM LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s SCM LifeScience Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — SCM LifeScience Co

All Key Metrics — SCM LifeScience Co